Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Why vote against the BOD and CEO at the AGM

<< Previous

Bullboard Posts

Next >>

Post by Garp1on Mar 14, 2023 5:45pm

166 Views

Post# 35338478

Why vote against the BOD and CEO at the AGM

Because the 1 million options he got at 1.29 could lead him to try to dump the company at a small price and hand him a golden parachute to exit. It is common in business to make option package vested when there is a buy out.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China